Medtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump’s built-in alerts and alarms for battery status and to contact Medt

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/voluntary-recall-notifying-medtronic-insulin-pump-users-potential-risks-shortened-pump-battery-life